Army 947th Forward Surgical Team,
Bagram AFB, Afghanistan
Congress designated The Army as the lead agent for DoD vaccine,
drug, and development programs for medical countermeasures to battlefield
threats. This includes vaccines against naturally occurring infectious
diseases of military significance, combat casualty care, military
operational medicine, and telemedicine research. The program also
funds Food and Drug Administration requirements for technology transition
to advanced development.
The medical force provides the requisite medical intervention and
care for the Joint Force deployed around the globe. With its Medical
Reengineering Initiative (MRI),
The Army Medical Department has transformed 28% of its Corps, and
echelon above Corps, force structure to an organizational structure
that promotes scalability through easily tailored, capabilities-based
packages. These packages result in improved tactical mobility, reduced
footprint, and increased modularity for flexible task organization.
MRI supports both the current forces and the Stryker Brigades, and
is the bridge to the Objective Medical Force. We have implemented
innovative strategies make the most efficient use of our budget.
Medical modernization, which includes the acquisition of current
medical equipment and technology, is partially funded within MRI